The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2

Mutation Research. Genetic Toxicology and Environmental Mutagenesis
Sylwia SpryszyńskaMaciej Stępnik

Abstract

The effect of inhibitors of phosphatidylinositol-3-kinase related kinases (PIKK): ataxia-telangiectasia mutated (ATM), ATM- and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) on the response of HepG2 human liver cancer cells to dibenzo[def,p]chrysene (DBC) was investigated. High cytotoxicity of DBC (IC50=0.1μM) was observed after 72h incubation. PIKK inhibitors: KU55933 (5μM), NU7026 (10μM) or caffeine (1 and 2mM) when used alone did not significantly influence the cytotoxicity. However, two combinations: KU55933/NU7026 and caffeine/NU7026 significantly increased HepG2 viability (by 25%) after treatment with DBC at 0.5μM. The cytoprotective effect was confirmed by cell cycle and apoptosis/necrosis analysis. DNA damage level after exposure to DBC assessed by comet assay (single strand breaks) showed a long persistence and significant decrease after incubation of the cells in the presence the inhibitors (the combination of KU55933+NU7026 showed the strongest effect). Weak induction of reactive oxygen species (ROS) by DBC (0.5μM) was observed. Although, KU55933 and NU7026 when used alone did not increase ROS levels in the cells, their combination induced the ROS increase and moderately enhanced ROS generation by DBC....Continue Reading

References

Mar 1, 1988·Experimental Cell Research·N P SinghE L Schneider
Jul 1, 1993·Mutation Research·V J McKelvey-MartinA Collins
May 20, 2006·Cancer Letters·Ann M Bode, Zigang Dong
Dec 22, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Maria MalmlöfUlla Stenius
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yannick AuclairElliot A Drobetsky
Oct 8, 2009·Cancer Research·Sébastien BrittonPatrick Calsou
Mar 3, 2010·Free Radical Biology & Medicine·Prakash PeddiAlexandros G Georgakilas
Mar 20, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ariane Ambolet-CamoitMartine Aggerbeck
Oct 5, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Chunlan YanJun Yang
Mar 16, 2012·The Biochemical Journal·Rebecca M Jones, Eva Petermann
Oct 31, 2012·Pharmacology & Therapeutics·John M Furgason, El Mustapha Bahassi
Jan 15, 2014·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Emily W Y TungLouise M Winn

❮ Previous
Next ❯

Citations

Jul 20, 2017·Toxicology Mechanisms and Methods·Francisco Filipak NetoCiro Alberto de Oliveira Ribeiro
May 6, 2016·Current Protocols in Toxicology·Filomena S G SilvaSusana P Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis